Home Infusion Therapy Market Is Projected To Grow At A CAGR Of 8.6% Over The Coming 10 Years

Home Infusion Therapy

Home Infusion Therapy Market Outlook

Newly-released Home Infusion Therapy industry analysis report by Fact.MR shows that global sales of Home Infusion Therapy in 2021 was held at US$ 31 Bn. With 8.6%, the projected market growth during 2022 – 2032 is expected to be significantly higher than the historical growth. Infusion Pumps is expected to be the highest revenue-generating product, accounting for an absolute dollar opportunity of nearly US$ 301 Bn during 2022 – 2032.

.To remain ‘ahead’ of your competitors, request a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=7169

Prominent Key players of the Home Infusion Therapy market survey report:

  • CVS/Coram
  • Option Care Health
  • BriovaRx/Diplomat
  • PharMerica
  • Fresenius Kabi
  • ICU Medical, Inc.
  • B. Braun Melsungen AG
  • Baxter
  • BD
  • Caesarea Medical Electronics
  • Smiths Medical
  • Terumo Corporation
  • JMS Co. Ltd.

Market Segments Covered in Home Infusion Therapy Industry Analysis

  • By Product Type :
    • Infusion Pumps
      • Elastomeric
      • Electromechanical
      • Gravity
      • Other Infusion Pumps
    • Intravenous Sets
    • IV Cannulas
    • Needless Connectors
  • By Application Type :
    • Anti-Infective
    • Endocrinology
    • Hydration Therapy
    • Chemotherapy
    • Enteral Nutrition
    • Parenteral Nutrition
    • Specialty Pharmaceuticals
    • Other Applications
  • By Region :
    • North America
    • Latin America
    • Europe
    • APAC
    • MEA

Leave a Reply

Your email address will not be published.